nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients
|
Yamamoto, Kazuhiro |
|
2015 |
11 |
1 |
p. 93-99 |
artikel |
2 |
Author’s Reply to Christelle de la Fouchardière: “Regorafenib: Start Low and Go Slow”
|
Tabchi, Samer |
|
2015 |
11 |
1 |
p. 127-128 |
artikel |
3 |
Comment on: “Regorafenib: Start Low and Go Slow”
|
de la Fouchardière, Christelle |
|
2015 |
11 |
1 |
p. 123-125 |
artikel |
4 |
Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study
|
Fouchardiere, Christelle de la |
|
2015 |
11 |
1 |
p. 71-82 |
artikel |
5 |
Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
|
Ipenburg, Norbertus A. |
|
2015 |
11 |
1 |
p. 17-27 |
artikel |
6 |
Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
|
Liffers, Katrin |
|
2015 |
11 |
1 |
p. 29-40 |
artikel |
7 |
HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases
|
Dozono, Haruhiko |
|
2015 |
11 |
1 |
p. 101-106 |
artikel |
8 |
Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis
|
Guetz, Gaetan Des |
|
2015 |
11 |
1 |
p. 41-47 |
artikel |
9 |
Lenvatinib: A Review in Refractory Thyroid Cancer
|
Frampton, James E. |
|
2016 |
11 |
1 |
p. 115-122 |
artikel |
10 |
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma
|
Greig, Sarah L. |
|
2016 |
11 |
1 |
p. 107-114 |
artikel |
11 |
RETRACTED ARTICLE: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials
|
Liu, Jin |
|
2015 |
11 |
1 |
p. 49-58 |
artikel |
12 |
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
|
Rouyer, Magali |
|
2015 |
11 |
1 |
p. 83-92 |
artikel |
13 |
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
|
Pistollato, Francesca |
|
2015 |
11 |
1 |
p. 1-16 |
artikel |
14 |
Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma
|
Kramkimel, N. |
|
2015 |
11 |
1 |
p. 59-69 |
artikel |